Literature DB >> 34850044

The Expanded Role of Ovarian Suppression for Young Women's Breast Cancer: An Era of Patient-Tailored Decision Making.

Virginia F Borges1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34850044      PMCID： PMC8902337          DOI： 10.1093/jnci/djab214

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  37 in total

1.  Age at any full-term pregnancy and breast cancer risk.

Authors:  W C Chie; C Hsieh; P A Newcomb; M P Longnecker; R Mittendorf; E R Greenberg; R W Clapp; K P Burke; L Titus-Ernstoff; A Trentham-Dietz; B MacMahon
Journal:  Am J Epidemiol       Date:  2000-04-01       Impact factor: 4.897

2.  Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Authors:  A S Coates; E P Winer; A Goldhirsch; R D Gelber; M Gnant; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2015-05-04       Impact factor: 32.976

3.  Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

Authors:  Halle C F Moore; Joseph M Unger; Kelly-Anne Phillips; Frances Boyle; Erika Hitre; David Porter; Prudence A Francis; Lori J Goldstein; Henry L Gomez; Carlos S Vallejos; Ann H Partridge; Shaker R Dakhil; Agustin A Garcia; Julie Gralow; Janine M Lombard; John F Forbes; Silvana Martino; William E Barlow; Carol J Fabian; Lori Minasian; Frank L Meyskens; Richard D Gelber; Gabriel N Hortobagyi; Kathy S Albain
Journal:  N Engl J Med       Date:  2015-03-05       Impact factor: 91.245

Review 4.  Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.

Authors:  Hatem A Azim; Luigi Santoro; William Russell-Edu; George Pentheroudakis; Nicholas Pavlidis; Fedro A Peccatori
Journal:  Cancer Treat Rev       Date:  2012-07-09       Impact factor: 12.111

5.  Antagonism of the cytocidal activity and uptake of melphalan by tamoxifen in human breast cancer cells in vitro.

Authors:  G J Goldenberg; E K Froese
Journal:  Biochem Pharmacol       Date:  1985-03-15       Impact factor: 5.858

Review 6.  Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Alison W Loren; Pamela B Mangu; Lindsay Nohr Beck; Lawrence Brennan; Anthony J Magdalinski; Ann H Partridge; Gwendolyn Quinn; W Hamish Wallace; Kutluk Oktay
Journal:  J Clin Oncol       Date:  2013-05-28       Impact factor: 44.544

7.  Treatment-related amenorrhea and sexual functioning in young breast cancer survivors.

Authors:  Shoshana M Rosenberg; Rulla M Tamimi; Shari Gelber; Kathryn J Ruddy; Sharon L Bober; Sandra Kereakoglow; Virginia F Borges; Steven E Come; Lidia Schapira; Ann H Partridge
Journal:  Cancer       Date:  2014-05-28       Impact factor: 6.860

8.  Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.

Authors:  Halle C F Moore; Joseph M Unger; Kelly-Anne Phillips; Frances Boyle; Erika Hitre; Anna Moseley; David J Porter; Prudence A Francis; Lori J Goldstein; Henry L Gomez; Carlos S Vallejos; Ann H Partridge; Shaker R Dakhil; Agustin A Garcia; Julie R Gralow; Janine M Lombard; John F Forbes; Silvana Martino; William E Barlow; Carol J Fabian; Lori M Minasian; Frank L Meyskens; Richard D Gelber; Gabriel N Hortobagyi; Kathy S Albain
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

9.  Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors.

Authors:  Tal Sella; Philip D Poorvu; Kathryn J Ruddy; Shari I Gelber; Rulla M Tamimi; Jeffrey M Peppercorn; Lidia Schapira; Virginia F Borges; Steven E Come; Ann H Partridge; Shoshana M Rosenberg
Journal:  Cancer       Date:  2021-04-22       Impact factor: 6.921

10.  Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects.

Authors:  G Albrektsen; I Heuch; S Hansen; G Kvåle
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.